Design (Testphase)
Momentum & Trend
Stan Weinstein: Stage 1
219
Hits
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 25 hits from US
Weinstein Stage 1 — basing: the price moves sideways and the 30-week line (150-day SMA) flattens out after a downtrend. Not yet a buy — wait until the uptrend (Stage 2) begins.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- SMA / Moving Average (10-, 20-, 50-, 200-Day Line)
- The average price of the last X days, plotted as a line on the chart (Simple Moving Average). The 50-day and 200-day lines are the most closely watched: price above the line = uptrend intact. The 30-week line from the Weinstein method corresponds to the 150-day line.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HYMC Hycroft Mining Holding Corporation | 07/29 | +212 % | 51 5/23 | Stage 1 | D -22 | 4 of 9 | 2.0 | Gold | Neutral | — | — | Basic Materials | 18.80 $ | -2.7 % | -6.3 % | +573.9 % | −62.7 % | -40.6 % | 97 | 42 | 8.2 % | 8.0 % | 2.72 | — | 0.0 | — | 9.7 | — | — | -0.8 | — | -341.0 % | 0.0 % | -86.1 % | -26.8 % | 0.00 | — | -100.0 % | 0.0 % | 0.0 % | 0.6 | 33.1 % | 19.4 % | — |
| CELC Celcuity LLC | 08/13 | +65 % | 80 7/22 | Stage 1 | C -6 | 2 of 9 | 4.8 | Biotechnology | Neutral | — | — | Healthcare | 88.00 $ | -9.6 % | -0.1 % | +741.8 % | −36.5 % | +67.5 % | 96 | 42 | 5.5 % | 7.2 % | 0.16 | — | 0.0 | 23,765.0 | — | — | — | -7.8 | 0.0 % | — | 0.0 % | -275.2 % | -37.1 % | — | 13.1 % | — | 0.0 % | 0.0 % | 2.6 | 101.2 % | 32.9 % | 1.0 (7) |
| OMER Omeros Corporation | 08/13 | -8 % | 80 7/22 | Stage 1 | B +32 | 6 of 9 | 0.8 | Biotechnology | – | — | — | Healthcare | 9.60 $ | -39.0 % | -35.5 % | +231.7 % | −39.3 % | +207.8 % | 91 | 42 | 10.1 % | 8.1 % | 2.55 | 7.6 | 58.1 | 78.5 | 8.4 | — | 0.81 | -1.5 | — | -190.5 % | 871.0 % | -576.3 % | -25.2 % | -4.91 | — | -100.0 % | 0.0 % | 0.0 % | -1.8 | 44.5 % | 25.9 % | — |
| ARMP Armata Pharmaceuticals Inc | 08/11 | +51 % | 56 5/22 | Stage 1 | D -42 | 4 of 9 | 0.2 | Biotechnology | Neutral | — | — | Healthcare | 5.10 $ | +11.6 % | +0.8 % | +299.5 % | −60.2 % | +169.2 % | 91 | 42 | 11.0 % | 10.5 % | 1.27 | — | 0.0 | 45.5 | — | — | — | -3.5 | — | -215.2 % | 0.0 % | -3,439.4 % | -25.3 % | — | — | -5.2 % | 0.0 % | 0.0 % | -52.2 | 10.5 % | 1.9 % | — |
| SATS EchoStar Corporation | 07/30 | +170 % | 84 8/24 | Stage 1 | D -45 | 4 of 9 | 28.2 | Telecom Services | Neutral | — | — | Communication Services | 92.00 $ | -4.4 % | -5.7 % | +298.7 % | −34.0 % | +41.7 % | 90 | 5 | 6.8 % | 7.3 % | 0.96 | — | 1.9 | 1.9 | 5.0 | — | 1.33 | 19.6 | 8.9 % | 27.1 % | -97.6 % | -112.3 % | 0.4 % | 5.20 | 13.6 % | -5.2 % | 0.0 % | 0.0 % | -0.9 | 112.2 % | 36.5 % | 1.6 (7) |
| TYRA Tyra Biosciences Inc | 08/13 | +24 % | 88 8/22 | Stage 1 | E -54 | 2 of 9 | 1.9 | Biotechnology | – | — | — | Healthcare | 31.10 $ | +14.3 % | +23.3 % | +212.8 % | −23.9 % | +68.0 % | 90 | 42 | 6.3 % | 6.2 % | 0.76 | — | 0.0 | — | 4.7 | — | — | -7.0 | — | — | 0.0 % | -36.9 % | -23.6 % | 0.02 | — | — | 0.0 % | 0.0 % | 20.5 | 111.6 % | 30.7 % | — |
| ZURA Zura Bio Limited Class A Ordinary Shares | 08/13 | -21 % | 42 4/22 | Stage 1 | D -38 | 3 of 9 | 0.4 | Biotechnology | – | — | — | Healthcare | 5.30 $ | -17.8 % | +25.1 % | +280.4 % | −39.0 % | +245.1 % | 90 | 42 | 9.7 % | 8.0 % | -0.04 | — | 0.0 | — | — | — | — | -2.3 | — | — | 0.0 % | -41.0 % | -25.4 % | — | — | — | 0.0 % | 0.0 % | 23.1 | 78.6 % | 8.3 % | — |
| CENX Century Aluminum Company | 08/06 | +146 % | 91 9/23 | Stage 1 | B +35 | 6 of 9 | 4.5 | Aluminum | Neutral | — | — | Basic Materials | 42.80 $ | +20.8 % | +18.4 % | +159.0 % | −34.7 % | +71.2 % | 87 | 97 | 6.7 % | 6.7 % | 1.97 | — | 6.5 | 1.8 | — | 166.5 | 0.06 | 10.4 | 13.3 % | 12.2 % | 13.7 % | 32.3 % | 5.5 % | — | 43.4 % | +13.9 % | 0.0 % | 0.0 % | 5.2 | 74.5 % | 12.0 % | 1.0 (3) |
| AMPX Amprius Technologies Inc. | 08/06 | +25 % | 90 11/29 | Stage 1 | B +21 | 5 of 9 | 1.8 | Electrical Equipment & Parts | Neutral | — | Industrials | 10.10 $ | +79.0 % | +58.5 % | +262.9 % | −48.2 % | +76.2 % | 87 | 42 | 8.7 % | 9.8 % | 2.26 | — | 0.0 | 19.7 | 16.7 | — | — | -34.5 | -23.4 % | 18.1 % | -44.0 % | -44.2 % | -10.6 % | 0.06 | 83.7 % | +202.1 % | 0.0 % | 0.0 % | 5.9 | 65.2 % | 16.4 % | 1.1 (7) | |
| RHLD Resolute Holdings Management, Inc. | 08/06 | — | — | Stage 1 | D -15 | 3 of 9 | 0.0 | Specialty Business Services | – | — | — | Industrials | 133.50 $ | -40.0 % | -36.8 % | +313.5 % | −47.1 % | — | 87 | 50 | 6.6 % | 6.5 % | — | 18.2 | 0.0 | — | 34.1 | — | — | 43.2 | — | 47.2 % | 7.7 % | 1.2 % | 2.2 % | 72.19 | — | +9.9 % | 0.0 % | 0.0 % | 3.7 | 47.7 % | 12.2 % | — |
| CAMP CAMP4 THERAPEUTICS CORPORATION | 08/13 | — | 70 6/22 | Stage 1 | D -22 | 5 of 9 | 0.2 | Biotechnology | – | — | — | Healthcare | 3.30 $ | -28.9 % | -25.0 % | +156.7 % | −49.4 % | +119.0 % | 85 | 42 | 12.9 % | 10.7 % | — | — | 0.0 | 53.1 | 7.1 | — | — | 0.0 | — | -871.4 % | 0.0 % | -209.3 % | -38.7 % | 0.07 | — | +436.5 % | 0.0 % | 0.0 % | -4.0 | 86.6 % | 1.1 % | — |
| GSIT GSI Technology Inc | 07/30 | -20 % | 47 5/25 | Stage 1 | D -38 | 4 of 9 | 0.3 | Semiconductors | – | — | — | Technology | 5.60 $ | +10.6 % | +13.0 % | +104.0 % | −62.0 % | +16.1 % | 85 | 42 | 7.3 % | 10.1 % | 2.06 | — | 66.2 | 10.4 | 3.2 | — | 74.00 | -6.1 | — | 54.5 % | -52.7 % | -24.1 % | -15.5 % | 0.10 | — | +22.4 % | 0.0 % | 0.0 % | 10.7 | 28.7 % | 7.0 % | — |
| KYTX Kyverna Therapeutics, Inc. Common Stock | 08/11 | — | 41 4/22 | Stage 1 | D -42 | 3 of 9 | 0.5 | Biotechnology | – | — | — | Healthcare | 7.20 $ | -10.3 % | -2.3 % | +167.7 % | −40.0 % | +270.7 % | 85 | 42 | 6.0 % | 6.2 % | 1.88 | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -74.6 % | -39.6 % | — | — | -100.0 % | 0.0 % | 0.0 % | 2.1 | 74.3 % | 11.8 % | — |
| ALB Albemarle Corp | 07/29 | -10 % | 66 6/23 | Stage 1 | B +27 | 7 of 9 | 17.4 | Specialty Chemicals | – | — | — | Basic Materials | 118.20 $ | +6.6 % | -12.2 % | +159.2 % | −36.2 % | +48.7 % | 84 | 10 | 4.9 % | 4.8 % | 1.35 | — | 14.2 | 3.2 | 2.1 | 30.1 | 0.79 | 33.5 | 24.8 % | 18.5 % | -4.2 % | -1.8 % | 1.6 % | 0.23 | 65.1 % | -4.4 % | 1.2 % | 69.2 % | 7.1 | 96.3 % | 0.1 % | 1.8 (28) |
| FOSL Fossil Group Inc | 08/12 | +20 % | 52 7/31 | Stage 1 | D -32 | 4 of 9 | 0.3 | Footwear & Accessories | – | — | — | Consumer Cyclical | 4.10 $ | +6.6 % | +16.3 % | +210.0 % | −27.4 % | +67.9 % | 84 | 6 | 5.5 % | 6.1 % | 1.63 | — | 166.7 | 0.3 | 2.6 | — | 1.23 | 98.6 | — | 55.7 % | -6.2 % | -58.5 % | 2.6 % | 3.49 | — | -12.3 % | 0.0 % | 0.0 % | 4.4 | 61.0 % | 5.4 % | — |
| DBI Designer Brands Inc | — | -10 % | 33 5/31 | Stage 1 | C -7 | 5 of 9 | 0.3 | Footwear & Accessories | – | — | — | Consumer Cyclical | 5.70 $ | -16.9 % | -20.1 % | +180.8 % | −35.8 % | +31.6 % | 83 | 76 | 6.6 % | 7.5 % | 1.25 | 28.4 | 9.5 | 0.1 | 1.1 | 2.7 | 2.34 | 11.1 | — | 44.2 % | 0.4 % | 5.6 % | 2.3 % | 4.37 | — | -3.9 % | 3.6 % | 46.4 % | 4.3 | 86.5 % | 36.1 % | — |
| SHIM Shimmick Corporation Common Stock | 08/13 | — | 49 6/29 | Stage 1 | D -19 | 4 of 9 | 0.2 | Engineering & Construction | Neutral | — | — | Industrials | 3.70 $ | +25.3 % | +50.2 % | +133.3 % | −39.7 % | +83.8 % | 83 | 42 | 7.6 % | 8.4 % | 0.71 | — | 72.5 | 0.4 | 69.8 | — | — | 1,635.2 | — | 8.7 % | -4.4 % | -696.6 % | -4.3 % | -1.33 | — | +2.6 % | 0.0 % | 0.0 % | 0.3 | 8.7 % | 0.2 % | — |
| FSLY Fastly, Inc. Class A Common Stock | 08/05 | +3 % | 87 9/25 | Stage 1 | B +27 | 7 of 9 | 2.5 | Software - Application | – | — | — | Technology | 20.50 $ | +63.7 % | +70.8 % | +142.3 % | −53.4 % | +48.7 % | 82 | 42 | 6.4 % | 7.4 % | 0.34 | — | 54.9 | 3.9 | 2.7 | 46.4 | — | -18.4 | -13.8 % | 59.4 % | -15.8 % | -10.7 % | -4.4 % | 0.41 | 64.6 % | +14.8 % | 0.0 % | 0.0 % | 3.7 | 90.9 % | 13.9 % | 2.1 (10) |
| IMNM Immunome Inc | 08/05 | +82 % | 56 5/22 | Stage 1 | D -11 | 3 of 9 | 2.2 | Biotechnology | – | — | — | Healthcare | 22.20 $ | -10.0 % | -5.8 % | +126.0 % | −29.8 % | +84.4 % | 81 | 42 | 5.0 % | 5.4 % | 2.07 | — | 0.0 | 544.5 | 3.8 | — | — | -0.7 | -5,698.8 % | -4,552.4 % | 0.0 % | -50.1 % | -29.7 % | 0.01 | 95.0 % | -23.2 % | 0.0 % | 0.0 % | 22.6 | 108.4 % | 18.8 % | 1.0 (9) |
| IHRT iHeartMedia Inc Class A | 08/10 | +5 % | 50 5/24 | Stage 1 | D -47 | 4 of 9 | 0.6 | Broadcasting | – | — | — | Communication Services | 4.00 $ | -6.0 % | -0.4 % | +129.6 % | −37.4 % | +0.4 % | 81 | 89 | 7.6 % | 8.1 % | 2.20 | — | 62.5 | 0.2 | — | — | 11.30 | 19.4 | — | 58.6 % | -7.3 % | -2,444.0 % | 2.7 % | — | — | +0.3 % | 0.0 % | 0.0 % | 0.7 | 86.6 % | 8.0 % | — |
| GOLD Gold.com, Inc. | — | +10 % | 55 5/22 | Stage 1 | C -1 | 5 of 9 | 1.2 | Capital Markets | – | — | — | Financial Services | 37.60 $ | +25.5 % | +19.2 % | +104.3 % | −37.9 % | +58.7 % | 80 | 82 | 3.9 % | 4.1 % | 0.61 | — | 12.6 | 0.1 | — | 10.7 | — | 9.0 | — | 1.8 % | 0.4 % | 10.8 % | 2.8 % | — | — | +13.2 % | 1.8 % | 21.5 % | 4.7 | 60.0 % | 16.2 % | — |
| LTRX Lantronix Inc | 08/26 | +14 % | 74 7/25 | Stage 1 | C +2 | 8 of 9 | 0.2 | Communication Equipment | – | — | — | Technology | 5.30 $ | +4.1 % | -1.7 % | +129.6 % | −39.2 % | +86.1 % | 80 | 42 | 6.9 % | 7.4 % | 1.70 | — | 18.9 | 2.0 | 3.3 | 28.1 | 0.91 | 24.6 | — | 43.0 % | -5.5 % | -8.7 % | -2.7 % | 0.23 | — | -23.3 % | 0.0 % | 0.0 % | 0.8 | 37.8 % | 2.5 % | — |
| STOK Stoke Therapeutics Inc | 08/11 | +60 % | 56 5/22 | Stage 1 | D -33 | 1 of 9 | 1.9 | Biotechnology | – | — | — | Healthcare | 27.70 $ | -2.0 % | +0.7 % | +162.2 % | −24.4 % | +48.4 % | 79 | 42 | 5.1 % | 4.9 % | 1.18 | — | 204.1 | 59.3 | 5.0 | — | — | 52.5 | -857.6 % | 100.0 % | 0.0 % | -45.6 % | -27.2 % | 0.01 | 89.1 % | +404.5 % | 0.0 % | 0.0 % | 10.1 | 120.3 % | 19.6 % | 1.1 (10) |
| RDZN Roadzen Inc. | — | -31 % | 74 7/25 | Stage 1 | C +1 | 4 of 9 | 0.1 | Software - Application | Sells AI | — | — | Technology | 1.20 $ | -36.1 % | -24.9 % | +41.2 % | −43.4 % | +244.8 % | 79 | 42 | 9.6 % | 8.4 % | 1.20 | — | 0.0 | 2.4 | — | — | — | -4.4 | — | 61.3 % | -40.9 % | 0.0 % | -20.5 % | — | — | -5.2 % | 0.0 % | 0.0 % | -20.2 | 3.0 % | 1.2 % | — |
| AA Alcoa Corp | 07/16 | +25 % | 37 4/23 | Stage 1 | C -1 | 2 of 9 | 14.0 | Aluminum | – | — | — | Basic Materials | 43.50 $ | +4.0 % | +0.0 % | +83.9 % | −37.1 % | +44.2 % | 78 | 22 | 5.3 % | 5.5 % | 1.63 | 13.9 | 9.7 | 1.1 | 2.1 | 48.8 | 8.36 | 8.1 | 13.9 % | 16.3 % | 8.2 % | 15.4 % | 4.2 % | 0.36 | 41.0 % | +7.9 % | 0.8 % | 13.2 % | 5.2 | 84.2 % | 3.1 % | 1.4 (14) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Weinstein Stage 1 — basing: the price moves sideways and the 30-week line (150-day SMA) flattens out after a downtrend. Not yet a buy — wait until the uptrend (Stage 2) begins.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 219 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- Ameet Rai: Daily Liquidity
- CANSLIM Type RS
- Character Change (CC)
- Chris Perruna: Daily New Highs
- Chris Perruna: Within 15% of Highs
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Jeff Sun
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Cross Fire
- Mike Webster: Down Days Tell Screen
- Mike Webster: Power Trend Leader
- Mike Webster: Swing Trading List
- Near 52-Week High
- Oliver Kell: 52 Week Highs
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Power Trend
- Qullamaggie: Top Gainers 1M
- Qullamaggie: Top Gainers 3M
- Qullamaggie: Top Gainers 6M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: 1 Week Top Performers
- Richard Moglen: Gaps and Strong Moves
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 2
- Stan Weinstein: Stage 3
- Strength on Stress Days
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.